Grants > A New Role for Amyloid Precursor Protein as a Mechanical Linker in Neurons Updated On: Oct 2, 2026
BrightFocus Foundation Grant

A New Role for Amyloid Precursor Protein as a Mechanical Linker in Neurons

Amyloid-Beta
Ben Goult, PhD

Principal Investigator

Ben Goult, PhD

University of Liverpool

Liverpool, United Kingdom

About the Research Project

Program

BrightFocus Foundation

Award Type

Standard

Award Amount

$114,126

Active Dates

January 01, 2026 - December 31, 2027

Grant ID

CA2026002

Acknowledgement

This grant is funded through the Cross Border Grant Program in partnership with Fondation Vaincre Alzheimer.

Goals

Demonstrate that APP is under mechanical tension in neurons and test whether Alzheimer’s disease risk genes disrupt this force-sensitive signaling pathway.

Summary

Our preliminary data revealed for the first time that APP is connected to the force-generation machinery via its interaction with a protein called talin. When combined with the known capacity of APP molecules to interact with each other, this immediately indicated a new role for APP as a tension-bearing linkage and mechanical sensor, where APP cleavage in healthy brains may act as a signal to maintain synaptic health. This provides a big hypothesis for a mechanical basis of Alzheimer’s disease, where disruption of neuronal mechanics contributes to the mis-processing of APP.

Unique and Innovative

If we can prove that APP is a force-bearing molecule and under tension, this will transform the field of Alzheimer’s Disease as we will show a role for APP that is novel, and identify a new cause of the disease. The mechanical signaling machinery that would be maintaining this linkage is well studied in diseases like cancer. We predict that this study will validate a new therapeutic approach for treating Alzheimer’s by targeting neuronal mechanics to slow the spread, and there are a wide range of drugs already on the market for treating cellular mechanics in other diseases.

Foreseeable Benefits

If we can prove that APP is a force-bearing molecule and under tension, this will transform the field of Alzheimer’s Disease as we will show a role for APP that is novel, and identify a new cause of the disease. The mechanical signaling machinery that would be maintaining this linkage is well studied in diseases like cancer. We predict that this study will validate a new therapeutic approach for treating Alzheimer’s by targeting neuronal mechanics to slow the spread, and there are a wide range of drugs already on the market for treating cellular mechanics in other diseases.